Company Update (NYSE:STJ): St. Jude Medical to Present at the 34th Annual J.P. Morgan Healthcare Conference

[Business Wire] – St. Jude Medical, Inc. will present at the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13 in San Francisco. Michael T. Rousseau, incoming president and chief executive officer, will make a presentation about the company at approximately 10 a.m. Read more on this. St. Jude Medical Inc. (STJ) , valued at $17.23B, started trading this morning at $60.99. Today’s price range has been between $60.46 and $61.22 per share and has traded between $59.88 and $80.84 over the past 12 months. Priced at 15.49x this year’s forecasted earnings, STJ shares are relatively expensive compared to the industry’s -3.36x forward p/e ratio. And for those looking to make a return holding the stock, the company pays shareholders $1.16 per share annually in dividends, yielding 1.91%. According to a consensus of 23 analysts, the earnings estimate of $1.02 per share would be $0.01 worse than the year-ago quarter and a $0.04 sequential decrease. Investors should also note that the full-year EPS estimate of $3.93 is a $0.05 setback when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $1.48 Billion. If reported, that would be a 2.78% increase over the year-ago quarter. In terms of ratings, Deutsche Bank downgraded STJ from Buy to Hold (Jul 23, 2015). Previously, Wells Fargo upgraded STJ from Market Perform to Outperform. The average price target for STJ shares by the analysts covering the stock is $74.05, which is 21.41% above where the stock opened this morning. See more in (NYSE:STJ) Similar Articles: Company Update (NYSE:STJ): St. Jude Medical to Present at the 2015 Credit Suisse Healthcare Conference Market Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical to Present at the Morgan Stanley Global Healthcare Conference Company Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces Second Quarter 2015 Earnings Conference Call